---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-021086"
form_type: "8-K"
ticker: "PBYI"
cik: "0001401667"
company_name: "PUMA BIOTECHNOLOGY, INC."
filed_at: "2024-06-24T23:59:59+00:00"
generated_at: "2026-06-01T02:25:07.135717+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Puma Biotechnology shareholders approve 3M share increase for equity plan, elect directors

## Summary
- Shareholders approved amendment to increase shares under 2011 plan by 3M to 17,529,412; ISO grants extended to March 2034.
- All eight director nominees elected: Auerbach, Cesano, Dorval, Miller, Moyes, Senderowicz, Stuglik, Wilson.
- Ratified KPMG as independent auditor for fiscal 2024 with 40.2M votes for.
- Advisory say-on-pay approved with 30.7M for; board adopts annual frequency for future votes.

## SEC filing metadata
- accession: 0001437749-24-021086
- form_type: 8-K
- ticker: PBYI
- cik: 0001401667
- company_name: PUMA BIOTECHNOLOGY, INC.
- filed_at: 2024-06-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401667/000143774924021086/0001437749-24-021086-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401667/000143774924021086/pbyi20240621_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-021086
- JSON: https://secwatch.observer/filing/0001437749-24-021086.json
- Plain text: https://secwatch.observer/filing/0001437749-24-021086.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.